With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Vectorious is one of several companies offering implantable monitors for heart failure. It's betting that reading left atrial pressure with digital technology will improve treatment decisions and outcomes. By Deborah Erickson.
Subscribe now to read the full analysis
It is no secret that the EU Medical Device Regulation (MDR) is shaking up the industry, but it may come as a surprise to manufacturers of lower-risk, Class I devices that they may also be impacted. The deadline is May 26, 2020, so it is critical for makers of Class I devices to review the relevant regulatory changes and determine whether they need to take action to avoid a market withdrawal, according to Maetrics’ Peter Rose, who explains the key aspects of the regulation concerning Class I.
Subscribe now to read the full analysis
'Meet the Innovators' Season 2, Episode 10: A video interview with Andrew Bartynski, co-founder, AesculaTech. Los Angeles-based start-up, AesculaTech, Inc., is developing a platform of temperature-responsive smart materials, including their first product, AesculaGel, a punctal plug for the treatment of dry eye syndrome that is applied as a liquid then solidifies at body temperature and blocks tear ducts.
Subscribe now to read the full analysis